HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masao Sasamata Selected Research

ramosetron (Nasea)

5/2009[Pharmacological and clinical profile of ramosetron hydrochloride (Irribow), a novel therapeutic agent for irritable bowel syndrome with diarrhea].
2/2008Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents.
11/2007Effect of ramosetron on conditioned emotional stress-induced colonic dysfunction as a model of irritable bowel syndrome in rats.
7/2007Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masao Sasamata Research Topics

Disease

14Neoplasms (Cancer)
10/2012 - 05/2004
10Overactive Urinary Bladder (Overactive Bladder)
05/2012 - 05/2004
7Body Weight (Weight, Body)
03/2014 - 06/2004
5Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
01/2010 - 03/2006
4Hyperglycemia
03/2014 - 01/2012
4Cerebral Infarction
03/2013 - 04/2003
4Melanoma (Melanoma, Malignant)
08/2011 - 09/2004
4Prostatic Neoplasms (Prostate Cancer)
03/2011 - 05/2004
4Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
05/2009 - 07/2007
4Diarrhea
05/2009 - 07/2007
3Type 2 Diabetes Mellitus (MODY)
03/2014 - 01/2012
3Glucose Intolerance
09/2013 - 11/2009
3Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2012 - 03/2011
3Hypoglycemia (Reactive Hypoglycemia)
04/2012 - 11/2009
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2010 - 02/2008
3Hyponatremia
01/2009 - 01/2007
3Pain (Aches)
07/2008 - 05/2004
3Infarction (Infarctions)
02/2007 - 01/2003
2Inflammation (Inflammations)
07/2014 - 09/2013
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2013 - 12/2006
2Insulin Resistance
09/2013 - 12/2006
2Breast Neoplasms (Breast Cancer)
09/2011 - 03/2011
2Neoplasm Metastasis (Metastasis)
09/2011 - 07/2008
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2011 - 03/2011
2Lymphoma (Lymphomas)
06/2011 - 01/2005
2Experimental Arthritis
01/2008 - 04/2005
2Arthritis (Polyarthritis)
01/2008 - 04/2005
2Urge Urinary Incontinence (Urge Incontinence)
05/2007 - 01/2007
2Embolic Stroke
01/2007 - 01/2003
2Lower Urinary Tract Symptoms
09/2006 - 08/2004
2Edema (Dropsy)
11/2005 - 11/2004
2Pulmonary Hypertension
06/2005 - 08/2004
2Hypoxia (Hypoxemia)
06/2005 - 08/2004
2Right Ventricular Hypertrophy
06/2005 - 08/2004
2Cancer Pain
11/2004 - 05/2004
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2004 - 05/2004
2Hematoma
05/2003 - 04/2003
2Cerebral Hemorrhage
05/2003 - 04/2003
1Albuminuria
07/2014
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2014
1Weight Loss (Weight Reduction)
03/2014
1Hyperlipidemias (Hyperlipidemia)
09/2013
1Hyperinsulinism (Hyperinsulinemia)
09/2013
1Obesity
09/2013
1Triple Negative Breast Neoplasms
09/2011

Drug/Important Bio-Agent (IBA)

10sepantroniumIBA
10/2012 - 09/2007
9SurvivinIBA
09/2012 - 09/2007
8Solifenacin SuccinateFDA Link
01/2010 - 05/2004
8N- (6- methoxy- 5- (2- methoxyphenoxy)- 2- (pyrimidin- 2- yl)pyrimidin- 4- yl)- 2- phenylethenesulfonamide (YM598)IBA
02/2008 - 02/2004
7Endothelins (Endothelin)IBA
02/2008 - 05/2004
6Tamsulosin (Flomax)FDA LinkGeneric
11/2010 - 08/2004
5ipragliflozinIBA
07/2014 - 01/2012
5Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
08/2009 - 05/2004
5Pharmaceutical PreparationsIBA
01/2009 - 04/2005
4Glucose (Dextrose)FDA LinkGeneric
09/2013 - 12/2006
4Muscarinic AntagonistsIBA
01/2010 - 05/2004
4ramosetron (Nasea)IBA
05/2009 - 07/2007
4SodiumIBA
01/2009 - 11/2005
3Streptozocin (Streptozotocin)FDA Link
07/2014 - 01/2012
3Sodium-Glucose Transport ProteinsIBA
07/2014 - 01/2012
3Insulin (Novolin)FDA Link
09/2013 - 12/2006
3ElectrolytesIBA
01/2009 - 01/2007
3Arginine Vasopressin (Argipressin)IBA
01/2009 - 01/2007
3conivaptan (Vaprisol)FDA Link
01/2009 - 01/2005
3Vasopressin Receptors (Arginine Vasopressin Receptor)IBA
01/2009 - 01/2005
3Celecoxib (Celebrex)FDA Link
01/2008 - 01/2005
3salicylhydroxamic acid (SHAM)IBA
02/2007 - 05/2004
3Bosentan (Tracleer)FDA Link
11/2004 - 08/2004
2Blood Glucose (Blood Sugar)IBA
09/2013 - 11/2009
2Niacinamide (Nicotinamide)FDA LinkGeneric
09/2013 - 01/2012
2Therapeutic UsesIBA
09/2013 - 08/2004
2mirabegronIBA
03/2013 - 05/2012
2Docetaxel (Taxotere)FDA Link
08/2011 - 06/2011
2Hormones (Hormone)IBA
03/2011 - 09/2007
2Analgesics (Analgesic Drugs)IBA
07/2008 - 01/2005
2Serotonin (5 Hydroxytryptamine)IBA
02/2008 - 11/2007
2Loperamide (Imodium)FDA LinkGeneric
02/2008 - 07/2007
2loxoprofen (CS 600)IBA
01/2008 - 11/2005
2Mineral Oil (Liquid Paraffin)FDA LinkGeneric
01/2008 - 04/2005
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
01/2008 - 04/2005
2darifenacinFDA Link
02/2007 - 05/2004
2Tolterodine Tartrate (Detrol)FDA Link
02/2007 - 05/2004
2Vasopressins (Vasopressin)IBA
01/2007 - 01/2005
2Endothelin-1 (Endothelin 1)IBA
06/2006 - 05/2004
2Dinoprostone (PGE2)FDA Link
11/2005 - 01/2005
2CarrageenanIBA
11/2005 - 01/2005
2AtrasentanIBA
11/2004 - 09/2004
2SaltsIBA
09/2004 - 05/2004
2Collagenases (Collagenase)FDA Link
05/2003 - 04/2003
2Heparin (Liquaemin)FDA LinkGeneric
05/2003 - 04/2003
2AMPA Receptors (AMPA Receptor)IBA
04/2003 - 01/2003
2YM 872IBA
04/2003 - 01/2003
1Rituximab (Mabthera)FDA Link
10/2012
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2012
1Progesterone Receptors (Progesterone Receptor)IBA
09/2011
1Estrogens (Estrogen)FDA Link
09/2011

Therapy/Procedure

8Therapeutics
09/2011 - 01/2007
3Oral Administration
06/2005 - 07/2004
2Intravenous Administration
01/2007 - 01/2005
1Drug Therapy (Chemotherapy)
10/2012